Trials / Conditions / Squamous NSCLC
Squamous NSCLC
4 registered clinical trials studyying Squamous NSCLC — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placeb NCT07318883 | Shanghai Henlius Biotech | Phase 2 / Phase 3 |
| Not Yet Recruiting | Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqN NCT07073183 | CureVac | Phase 1 |
| Completed | Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced NCT03629925 | Innovent Biologics (Suzhou) Co. Ltd. | Phase 3 |
| Unknown | Phase II Study of Dovitinib for FGFR1 Amplified Squamous Non-small Cell Lung Cancer NCT01861197 | Samsung Medical Center | Phase 2 |